Dr. Sharmila Ahmed

My philosophy is to consider the patient a partner in health care and to involve him/her in discussions and decisions regarding treatment and prevention of disease. Dr. Li is rated as an Experienced provider by MediFind in the treatment of HELLP Syndrome. His top areas of expertise are Aase Syndrome, Metachondromatosis, Syndactyly Cenani Lenz Type, and X-Linked Severe Combined Immunodeficiency.

Swathi Namburi, MD, is a hematologist who specializes in treating a variety of blood cancer and blood disorders. Her clinical research interests include multiple myeloma and novel immunotherapy approaches for blood cancers. Dr. Namburi is part of the Center for Blood Disorders and Cellular Therapy at the Swedish Cancer Institute. She provides full-spectrum care for her patients. This includes initial consultation and diagnosis, treatment to help achieve remission, consideration and enrollment onto clinical trials open through Providence/Swedish health care, and long-term management and survivorship related care. She oversees her patients through CAR-T cell therapy and autologous stem cell transplantation as these needs come up during various phases of treatment. Dr. Namburi completed a fellowship in hematology/oncology at the University of Pittsburgh Medical Center. She completed her residency at the George Washington University Medical Center in DC, and prior to that attended medical school at Rutgers/UMDNJ in New Brunswick, NJ near to where she grew up in East Brunswick, NJ. She is board certified in internal medicine, medical oncology, and hematology. She can communicate in several languages including Telugu, Hindi, Spanish, and French and she liberally receives help from Swedish’s wonderful in-person medical translators. Dr. Namburi has been practicing in the Seattle-Tacoma region since 2018. She is a board member of the Washington State Medical Oncology Society and participates in the annual Washington State Medical Association meetings to help support state initiatives that will help our patients with cancer have access to excellent care and treatment. She regularly attends and presents her work at national and international hematology conferences. Dr. Namburi is rated as an Advanced provider by MediFind in the treatment of HELLP Syndrome. Her top areas of expertise are Diffuse Large B-Cell Lymphoma (DLBCL), Acute Myeloid Leukemia (AML), Multiple Myeloma, Large-Cell Immunoblastic Lymphoma, and Bone Marrow Aspiration.

Dr. Egan specializes in the care of patients with hematologic malignancies including leukemia, myelodysplastic syndrome, myeloproliferative disorders, as well as blood disorders such as anemia. His holistic partnership approach to treatment ensures patients are involved in decision-making that focuses on what is most important to them. Dr. Egan provides thorough education so patients can confidently understand their illness and treatment options, and helps patients navigate the variety of existing and emerging therapies. Dr. Egan is rated as a Distinguished provider by MediFind in the treatment of HELLP Syndrome. His top areas of expertise are Acute Myeloid Leukemia (AML), Chronic Myelogenous Leukemia (CML), Acute Myeloblastic Leukemia without Maturation, Bone Marrow Aspiration, and Bone Marrow Transplant.